INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Myriad Genetics, Inc. Investors
Investors suffering losses on their Myriad investments are encouraged to contact the
On
On this news, the Company’s stock price fell
The complaint filed in this class action alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company’s business, operations, and prospects. Specifically, Defendants failed to disclose to investors: (1) that Myriad's product, GeneSight, lacked evidence or information sufficient to support the tests in their current form, including their purported benefits; (2) that the FDA had requested changes to GeneSight and questioned the validity of the test’s purported benefits; (3) that Myriad had been in ongoing discussions with the FDA regarding the FDA’s requested changes to GeneSight; (4) that Myriad’s acquisition of Counsyl—and thereby, Foresight—caused the Company to incur the risk of suffering from lower reimbursement for its expanded carrier screening tests, which had the potential to, and actually did, materialize into a material negative impact on the Company’s revenue; and (5) that as a result, the Company’s public statements were materially false and misleading at all relevant times.
If you purchased Myriad securities, have information or would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact
This press release may be considered
View source version on businesswire.com: https://www.businesswire.com/news/home/20191007005190/en/
888-638-4847
[email protected]
www.howardsmithlaw.com
Source:
Mark Farrah Associates Presents 2020 Medicare Plan Benefits in Medicare Benefits Analyzer™
DNA testing scams in Florida, other states costing Medicare billions
Advisor News
Annuity News
Health/Employee Benefits News
Life Insurance News